I'm going to use this NYT article on dual-purpose diabetes/weight loss drugs to brag about my endocrinologist friend Brad (@endocrine) for a minute.
https://t.co/tkx0f0BwnR
The Casual Inference podcast is a smart, accessible look into data science, statistics, and more. (They have a buzzer that sounds if things get too technical!) And through a momentary lapse in good judgment, they had me on.
Listen to this and then start from the beginning.
These have been challenging times for all of us. In times like this, I think it is important for those of all blessed with health and means remember our brothers and sisters who are not so fortunate.
https://t.co/fXyNdfVYm8
The team at GlucosePATH wants to help. Let us know if any primary care or endocrine offices would like to use GlucosePATH free of charge to help with diabetes #telehealth throughout the crisis. We will work to match your major pharmacy coverage.
The team at GlucosePATH would like to congratulate @StElizabethNKY for such a great honor. Proud to be a partner of such an excellent organization. https://t.co/k0TXJG20n2
The team at GlucosePATH is looking for systems and providers looking for innovative ways to improve Type 2 Diabetes Care for patients on Medicaid. DM us if you would like to know more.
What happens when your child is diagnosed w/ #T1D at Disney World? Hear one family's surprising story: https://t.co/3WS2bwJC1Z plus #FFLOrlando2019 & more! #DSMA#DOC